---
title: "PharmaCielo Announces Intention to Issue Interest Shares | PCLOF Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283137056.md"
description: "PharmaCielo Announces Intention to Issue Interest Shares | PCLOF Stock News"
datetime: "2026-04-17T03:35:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283137056.md)
  - [en](https://longbridge.com/en/news/283137056.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283137056.md)
---

# PharmaCielo Announces Intention to Issue Interest Shares | PCLOF Stock News

PharmaCielo Announces Intention to Issue Interest Shares | PCLOF Stock News

### Related Stocks

- [SILO.US](https://longbridge.com/en/quote/SILO.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)

## Related News & Research

- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)
- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [<![CDATA[Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates]]>](https://longbridge.com/en/news/286787081.md)
- [Dogwood Therapeutics Announces Commencement of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Long Term Extension Study | DWTX Stock News](https://longbridge.com/en/news/286772955.md)
- [Wave Life Sciences posts positive RestorAATion-2 data; WVE-006 restores M-AAT, cuts Z-AAT, supports monthly dosing](https://longbridge.com/en/news/286818220.md)